Oral Antihyperglycemic Medication Nonadherence and Subsequent Hospitalization Among Individuals With Type 2 Diabetes
- 1 September 2004
- journal article
- conference paper
- Published by American Diabetes Association in Diabetes Care
- Vol. 27 (9) , 2149-2153
- https://doi.org/10.2337/diacare.27.9.2149
Abstract
OBJECTIVE—This study examines the association between oral antihyperglycemic medication nonadherence and subsequent hospitalization among individuals with type 2 diabetes. RESEARCH DESIGN AND METHODS—Using administrative claims data (2000–2001) from a managed care organization in the Midwestern U.S., this study analyzed 900 enrollees, aged 18 years and over, with type 2 diabetes who were taking oral antihyperglycemic agents both years but who did not use insulin. Nonadherence was defined as a medication possession ratio (MPR) <80%. Multivariate logistic regression analyses were performed where hospitalization in 2001 was regressed on nonadherence to the oral antihyperglycemic drug regimen in 2000, while controlling for nonadherence to drugs for hypertension and dyslipidemia and for hospitalization in 2000, age, sex, intensity of the diabetes drug regimen, and comorbidities. RESULTS—The proportion of enrollees who were nonadherent to the antihyperglycemic drug regimen in 2001 was 28.9%, whereas 18.8 and 26.9% were nonadherent to antihypertensive and lipid-modifying drugs, respectively. The increase in the hospitalization rate for 2001 was most apparent where the antihyperglycemic MPR for 2000 dropped to <80%. Enrollees who were nonadherent to oral diabetes medications in 2000 were at higher risk of hospitalization in 2001 (odds ratio 2.53; 95% CI 1.38–4.64), whereas nonadherence to drugs for hypertension and dyslipidemia were not significantly associated with hospitalization. CONCLUSIONS—Patients with type 2 diabetes who do not obtain at least 80% of their oral antihyperglycemic medications across 1 year are at a higher risk of hospitalization in the following year.This publication has 31 references indexed in Scilit:
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998
- Cardiovascular events and correlates in the Veterans Affairs Diabetes Feasibility Trial. Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type II DiabetesArchives of internal medicine (1960), 1997
- The impact of patient adherence on health outcomes for patients with chronic disease in the medical outcomes studyJournal of Behavioral Medicine, 1994
- Further evidence concerning the use of a clinical comorbidity index with ICD-9-CM administrative dataJournal of Clinical Epidemiology, 1993
- Presentation adapting a clinical comorbidity index for use with ICD-9-CM administrative data: Differing perspectivesJournal of Clinical Epidemiology, 1993
- Effect of value–added utilities on prescription refill compliance and Medicaid health care expenditures–a study of patients with non–insulin–dependent diabetes mellitusJournal of Clinical Pharmacy & Therapeutics, 1993
- A General Method of Compliance Assessment Using Centralized Pharmacy RecordsMedical Care, 1988
- Correlates of Medication Compliance in Non-Insulin-Dependent Diabetes MellitusSouthern Medical Journal, 1987
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987
- DETERMINANTS OF PATIENT COMPLIANCE, CONTROL, PRESENCE OF COMPLICATIONS, AND HANDICAP IN NON-INSULIN-DEPENDENT DIABETESAustralian and New Zealand Journal of Medicine, 1984